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Abstract
This dissertation includes three papers with each distributed in one chapter.
In chapter 1, we proposed an Adaptive Weighting Reverse Regression (AWRR) method to
test association between multiple traits and rare variants in a genomic region. AWRR is
robust to the directions of effects of causal variants and is also robust to the directions of
association of traits. Using extensive simulation studies, we compared the performance of
AWRR with canonical correlation analysis (CCA), Single-TOW, and the Weighted Sum
Reverse Regression (WSRR). Our results showed that, in all of the simulation scenarios,
AWRR is consistently more powerful than CCA. In most scenarios, AWRR is more
powerful than Single-TOW and WSRR.
In chapter 2, we proposed an “optimal” maximum heritability test (MHT-O) to test the
association between multiple traits and a single variant. MHT-O includes a procedure of
deleting traits that have weak or no association with the variant. Using extensive simulation
studies, we compared the performance of MHT-O with MHT, Trait-based Association Test
uses Extended Simes procedure (TATES), SUM_SCORE and MANOVA. Our results
showed that, in all of the simulation scenarios, MHT-O is either the most powerful test or
comparable to the most powerful test among the five tests we compared.
In chapter 3, we developed a statistical method by testing an optimally weighted
combination of variants with multiple traits (TOWmuT) to test the association between
multiple traits and a weighted combination of variants (rare and/or common) in a genomic
region. TOWmuT is robust to the directions of effects of causal variants and is applicable
to different types of traits. Using extensive simulation studies, we compared the
performance of TOWmuT with the following five existing methods: gene association with
multiple traits (GAMuT), multiple sequence kernel association test (MSKAT), adaptive
weighting reverse regression (AWRR), single-TOW, and MANOVA. Our results showed
that, in all of the simulation scenarios, TOWmuT has correct type I error rates and is
consistently more powerful than the other five tests. We also illustrated the usefulness of
TOWmuT by analyzing a whole-genome genotyping data from a lung function study.

xi

1 Chapter 1
Joint analysis of multiple traits in rare variant association studies
Abstract: The joint analysis of multiple traits has recently become popular since it can
increase statistical power to detect genetic variants and there is increasing evidence
showing that pleiotropy is a widespread phenomenon in complex diseases. Currently, most
of existing methods for the joint analysis of multiple traits are to test association between
one common variant and multiple traits. However, the variant-by-variant methods for
common variant association studies may not be optimal for rare variant association studies
due to the allelic heterogeneity as well as the extreme rarity of individual variants. Current
statistical methods for rare variant association studies are for one single trait only. In this
paper, we propose an Adaptive Weighting Reverse Regression (AWRR) method to test
association between multiple traits and rare variants in a genomic region. AWRR is robust
to the directions of effects of causal variants and is also robust to the directions of
association of traits. Using extensive simulation studies, we compare the performance of
AWRR with canonical correlation analysis (CCA), Single-TOW, and the Weighted Sum
Reverse Regression (WSRR). Our results show that, in all of the simulation scenarios,
AWRR is consistently more powerful than CCA. In most scenarios, AWRR is more
powerful than Single-TOW and WSRR.

Introduction
There is increasing evidence showing that pleiotropy, the effect of one variant on multiple
traits, is a widespread phenomenon in complex diseases [Sivakumaran et al., 2011].
Furthermore, in genetic association studies of complex diseases, multiple related traits are
usually measured. For example, hypertension is evaluated using systolic and diastolic
blood pressures, the Metabolic Syndrome is based on observing three of five criteria [Sattar
et al., 2008], and neuropsychiatric disorders depend on a range of overlapping clinical
characteristics[O'Reilly et al., 2012]. Although most published genome-wide association
studies (GWAS) analyze each of the related traits separately, the joint analysis of multiple
traits not only can increase statistical power to detect genetic variants [Solovieff et al.,
2013; Stephens, 2013; Yang & Wang, 2012; Zhou & Stephens, 2014], but also can be
crucial to understand the genetic architecture of the disease of interest [Aschard et al.,
2014]. Thus, the joint analysis of multiple traits has recently become popular. Several
statistical methods for the joint analysis of multiple traits have been developed. These
methods can be roughly divided into three groups: regression methods, combining test
statistics from univariate analysis, and dimension reduction methods. Regression methods
include mixed effects models [Korte et al., 2012; Zhou & Stephens, 2014] and reverse
regression models [O'Reilly et al., 2012; Yan et al., 2013]. By modeling the covariance
structure of correlated traits and dependence structure between individuals, mixed effects
models not only can incorporate multiple correlated traits, but also can be robust to
population stratification. Reverse regression models consider genotypes as the response
variable and all the traits as independent variables, therefore, reverse regression models do
1

not need to know the complex distributions of the traits and can be applied to a large
number of mixed types of traits. For combining the test statistics from univariate analysis,
one first obtains univariate test statistics by performing association tests for each trait
individually and then combines the univariate test statistics by linear combinations
[O'Brien, 1984; van der Sluis et al., 2013; Yang et al., 2010]. The dimension reduction
methods include canonical correlation analysis (CCA) [Tang & Ferreira, 2012], principal
components of traits (PCT) [Aschard et al., 2014], and principal components of heritability
(PCH) [Klei et al., 2008; Lange et al., 2004; Ott & Rabinowitz, 1999]. CCA is to find a
linear combination of traits and a linear combination of genotypes at multiple variants such
that the correlation between the two linear combinations reaches its maximum. PCT is the
principal component analysis to the traits. The PCT methods are usually based on the first
PC or first few PCs of the traits [Feng et al., 2007; Klei et al., 2008]. Aschard et al. (2014)
showed that contrary to the widespread practice, tests based on only the first few PCs often
have low power, whereas combining signals across all PCs can have greater power. PCH
is to find a linear combination of multiple traits such that this linear combination has the
maximum heritability.
Almost all of the aforementioned methods are to test association between one
common variant and multiple traits. However, the variant-by-variant methods for common
variant association studies may not be optimal for rare variant association studies due to
the allelic heterogeneity as well as the extreme rarity of individual variants [Li & Leal,
2008]. Recent studies show that complex diseases are caused by both common and rare
variants [Bodmer & Bonilla, 2008; Kang et al., 2010; Pritchard, 2001; Pritchard & Cox,
2002; Stratton & Rahman, 2008; Teer & Mullikin, 2010; Walsh & King, 2007]. Nextgeneration sequencing technology allows sequencing of the whole genome of large groups
of individuals, and thus makes rare variant association studies feasible [Andres et al., 2007;
Metzker, 2010]. Recently, statistical methods for rare variant association studies with a
single trait have been developed by summarizing genotype information from multiple
variants. These methods include burden tests [Li & Leal, 2008; Madsen & Browning, 2009;
Morgenthaler & Thilly, 2007; Price et al., 2010; Zawistowski et al., 2010], quadratic tests
[Neale et al., 2011; Sha et al., 2012; Wu et al., 2011], and combined tests [Derkach et al.,
2013; Lee et al., 2012; Sha & Zhang, 2014]. Burden tests collapse rare variants in a
genomic region into a single burden variable and then regress the trait on the burden
variable to test for the cumulative effects of rare variants in the region. These tests
implicitly assume that all rare variants are causal and that the directions of the effects are
all the same. Quadratic tests include tests with statistics of quadratic form of score vector,
as well as adaptive weighting methods. These tests are robust to the directions of the effects
of causal variants and are less affected by neutral variants than burden tests. Burden tests
can only outperform quadratic tests when most of rare variants are causal and the directions
of the effects of causal variants are all the same. Combined tests combine information from
burden tests, quadratic tests, and possibly other tests aiming to have advantages of multiple
tests.
In this article, we propose an adaptive weighting reverse regression (AWRR)
method to test association between multiple traits and rare variants in a genomic region. In
2

AWRR, we first propose adaptive weights to collapse genotypes. Then, we use the score
test to test association based on the reverse regression, in which collapsed genotypes is
treated as the response variable and multiple traits are treated as independent variables.
Using extensive simulation studies, we compare the performance of AWRR with CCA,
Single-TOW, and the Weighted Sum Reverse Regression (WSRR). In the Single-TOW,
we first calculate the TOW statistic [Sha et al., 2012] to test the association between each
trait and variants in a genomic region and then the statistic of Single-TOW is the largest of
TOW statistics. In the WSRR, we first calculate the weighted sum [Madsen & Browning,
2009] of genotypes at variants in a genomic region and then the statistic of WSRR is the
score test statistic under reverse regression model, in which the weighted sum of genotypes
is the response variable and traits are predictor variables. Our results show that, in all of
the simulation scenarios, AWRR is consistently more powerful than CCA. In most
scenarios, AWRR is more powerful than Single-TOW and WSRR.

3

Methods
We consider a sample with n unrelated individuals. Each individual has K (potentially
correlated) traits and has been genotyped at M variants in a genomic region. Let yik
denote the k th trait value of the i th individual. Let xim denote the genotype score of the m th
variant of the i th individual, where xim is the number of minor alleles of the i th individual
carried at the m th variant. We denote Yi = ( yi1 ,…, yiK ) as the K traits for the i th
individual. We propose an adaptive weighting reverse regression (AWRR) method to test
the null hypothesis H 0 : none of the K traits are associated with the M variants in the
genomic region. For constructing the test statistic of AWRR, we first collapse the M
T

M

dimensional genotype ( xi1 ,…, xiM ) into a one dimensional number xi = ∑wm xim , where wm
m =1

is the adaptive weight for the m variant. The adaptive weight wm should satisfy properties
that wm should be large if the m th variant has strong association with the K traits and wm
should have different signs for risk and protective variants. Then, the statistic of AWRR is
th

K

β 0 + ∑β k yik + ε i . In details,
the score test statistic under the reverse regression model xi =
k =1

the AWRR method has the following steps.

1. We define a weight Wm for the m th variant such that Wm will be large if the m th
variant has strong association with the K traits and Wm will be also large if the m th
1

variant is a rare variant. For these purposes, we propose Wm =

pm (1 − pm )

Tm ,

where pm is the minor allele frequency of the m th variant and Tm is the score
statistic to test the null hypothesis 𝐻𝐻0 : 𝛽𝛽1 = ⋯ = 𝛽𝛽𝐾𝐾 = 0 under the reverse
regression model log

pim
=
β 0 + β1 yi1 + + β K yiK , where we assume a dominant
1 − pim

=
pim Pr
=
1) Pr
=
model
( xim=
( xim 2 ) . In fact, for rare variants, xim essentially is 0 or
=
Um
1. The score statistic is given by Tm = U mTVm−1U m , where

n

∑Y ( x
i =1

i

im

− xm ) and

n
T
1 n
1 n
1 n
2
−
x
x
Y
−
Y
Y
−
Y
x
=
x
,
Y
=
,
where
and
(
)
)(
)
(
∑ im m ∑ i
∑ im
∑Yi . Under
i
m
n i =1
n i 1 =i 1
n i =1
=
the null hypothesis, Tm follows a χ 2 distribution with degrees of freedom K .
However, Wm does not consider the direction of the effects of causal variants.
2. In this step, we will define a direction of Wm . We first select a trait (the selected

=
Vm

trait denoted as the 𝑘𝑘�th trait). We use 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠�𝜌𝜌(𝑦𝑦𝑘𝑘� , 𝑥𝑥𝑚𝑚 )� to denote the direction of
the associations of the m th variant, where 𝑦𝑦𝑘𝑘� = (𝑦𝑦1𝑘𝑘� , … , 𝑦𝑦𝑛𝑛𝑘𝑘� ) and
4

T
xm = ( x1m ,…, xnm ) . If the 𝑘𝑘� th trait has no association with the M variants, the

directions of the association will be random. In order to try to avoid random
directions, we propose to choose the trait that has the strongest association with the
k
M variants. Let TTOW
denote the statistic of TOW [Sha et al., 2012] to test
k
association between the k th trait and the M variants. TTOW
is defined as
n

k
TTOW
= ∑( yik − yk )( xio − x o )
i =1
n

∑

,

xio = ∑ m =1 wmo xim
M

where

and

( y − y )( x − x ) / ∑ ( xim − xm ) 2 . We choose the 𝑘𝑘� th trait such that

n
O
m
ik
k
im
m
=
i 1
i 1=

w =
�

𝑘𝑘
𝑘𝑘
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇
= 𝑚𝑚𝑚𝑚𝑚𝑚 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇
.
1≤𝑘𝑘≤𝐾𝐾

3. The final weight for the m th variant is given by wm = sign ( ρ ( yk%, xm ) )Wm . Let
M

K

m =1

k =1

β 0 + ∑β k yik + ε i .
xi = ∑wm xim . Then, we consider the reverse regression model xi =

We apply a score test to test the null hypothesis 𝐻𝐻0 : 𝛽𝛽1 = ⋯ = 𝛽𝛽𝐾𝐾 = 0. The score
statistic

is

given

by

TAWRR = u TV −1u

,

u
where =

n

∑ ( x − x )Y
i =1

i

i

,

n
T
1 n
1 n
1 n
2
x
=
x
,
Y
=
x
−
x
Y
−
Y
Y
−
Y
,
and
(
)
∑i
∑Yi .
∑ i
∑ ( i )( i )
n i =1
n i =1
n i 1 =i 1
=
4. In this step, we evaluate the p-value of TAWRR . Since wm depends on the trait values
and the genotype scores, TAWRR does not follow a χ 2 distribution with degrees of
freedom K . We use a permutation procedure to evaluate the p-value of TAWRR . In
each permutation, we randomly shuffle Y1 ,…,Yn and keep the genotypes of each

=
V

individual unchanged. We repeat step 1 to step 3 based on each permutated data.
0
per
Let TAWRR
denote the test statistic of TAWRR based on the original data and TAWRR
denote the test statistic based on the permuted data. Then the p-value of the test
per
0
.
TAWRR is the proportion of the number of permutations with TAWRR
≥ TAWRR

Comparisons of Tests
We compare the performance of the proposed test AWRR with those of the canonical
correlation analysis (CCA) [Tang & Ferreira, 2012], the Single-TOW method [Sha et al.,
2012], and the Weighted Sum Reverse Regression (WSRR) method [Madsen & Browning,
2009].
CCA method: although the asymptotical distribution of the CCA statistic works
well for common variants, it is very conservative for rare variants. Thus, we propose to use
a permutation procedure to evaluate the p-value of the CCA statistic.

5

k
Single-TOW method: let TTOW
denote the statistic of TOW [Sha et al., 2012] to
th
test association between the k trait and the M variants. The statistic of Single-TOW is
k
given by TSingle−TOW = max1≤k ≤ K TTOW
. The p-value of TSingle −TOW is evaluated by a permutation

procedure.
M

WSRR method: let X i = ∑ wm xim , where wm = 1
m =1

pm (1 − pm ) and pm is the minor

allele frequency of the m th variant. We consider the reverse regression model
K

Xi =
β 0 + ∑β k yik + ε i . The statistic of WSRR, TWSRR , is the score test statistic to test the null
k =1

hypothesis H 0 : β1 = L = β K = 0 . Under the null hypothesis, TWSRR follows a χ 2 distribution
with degrees of freedom K .
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Simulation Study
Our simulations follow that of Sha et al. (2012). In details, the empirical Mini-Exome
genotype data provided by the genetic analysis workshop 17 (GAW17) is used for
simulation studies. This dataset contains genotypes of 697 unrelated individuals on 3205
genes. We will conduct two sets of simulations. In the first set of simulations, we choose
four genes: ELAVL4, MSH4, PDE4B, and ADAMTS4 with 10, 20, 30, and 40 variants,
respectively. We merge the four genes to form a super gene (Sgene1) with 100 variants
[Sha et al., 2012]. In the second set of simulations, we choose ten genes: ELAVL4,
FAM73A, PSMB4, FSHR, GMCL1, HNMT, GALNT13, NEUROD1, MYEOV2, and
TWF2 with 10 variants in each of them. We merge the ten genes to form a super gene
(Sgene2) with 100 variants. In our simulation studies, we generate genotypes based on the
genotypes of 697 individuals in the Sgene1 and Sgene2. To generate a qualitative disease
affection status, we use a liability threshold model based on a quantitative trait. For a
qualitative trait, an individual is defined to be affected if the individual’s corresponding
quantitative trait is at least one standard deviation larger than the phenotypic mean. This
yields a prevalence of 16% for the simulated disease in the general population. In the
following, we describe how to generate a quantitative trait.
To evaluate the type I error, we generate K traits of an individual independent of
the genotypes by using
Y=
yK )
( y1 ,…,=
T

where u = ( u1 ,…, un

u

)

T

ρ Βu + 1 − ρε ,

~ MVN ( 0, I ) is a vector of nu independent standard normal latent

ε ( ε1 ,…, ε K ) ~ MVN ( 0, I ) is a vector of errors, Β is a K × nu loading matrix,
variables, =
T

the values of nu and Β are based on two variance models: (1) nu = 1 , Β= (1,…,1) and (2)
T

 e[ K 2]
nu = 2 , Β = 
 0

0


T
 . Thus, Y ~ MVN ( 0, Σ ) , where Σ= ρΒΒ + (1 − ρ ) I .
eK −[ K 2] 

To evaluate power, we consider that all causal variants are rare (MAF<0.01). We
randomly choose nc rare variants as causal variants, where nc is determined by the
percentage of causal variants among rare variants. Denote nr and n p as the number of risk
nc . Let xqir and x jip
rare variants and protective rare variants, respectively, where nr + n p =

denote the genotypic scores of the q th risk rare variant and the j th protective rare variant
for the i th individual, respectively. Suppose that causal variants have impact on the L traits
among the K traits and, among the L traits, there are Lp traits positively correlated with
risk variants and there are Ln traits negatively correlated with risk variants. Let h denote
the heritability of all the nc rare causal variants on each of the L traits. Generate nc
random numbers r1 ,…, rn from an uniform distribution between 0 and 1. The heritability
c
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of the i th causal variant is given by hi = hri

nc

∑r
j =1

j

. Under this assumption, we simulated K

traits by
 nr r r n p p p
1 ≤ k ≤ Lp
 ∑ β kq xqi − ∑ β kj x ji + ε ik ,
=
 q 1 =j 1
np
  nr


r r
=
yik  −  ∑ β kq xqi − ∑ β kjp x jip  + ε ik , Lp + 1 ≤ k ≤ L ,
=

  q 1 =j 1
ε ,
L<k ≤K
 ik


where ε i = (ε i1 ,…, ε iK ) can be generated in the same way as generating traits of evaluating
T

type I error, β kqr and β kjp are constants and their values depend on the heritability.
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Results
For type I error evaluation, we only consider the first set of simulations, but consider
different sample sizes, different significance levels, different variance models and different
types of traits. In each simulation scenario, the p-values of AWRR, Single-TOW and CCA
are estimated by 10,000 permutations (the p-values of WSRR are estimated by a χ 2
distribution) and the type I error rates of all of the four tests are evaluated using 10,000
replicated samples. For 10,000 replicated samples, the 95% confidence intervals (CIs) for
the type I error rates at the nominal levels 0.05 and 0.01 are (0.046, 0.054) and (0.008,
0.012), respectively. The estimated type I error rates of the four tests are summarized in
Tables 1.2, 2.2, A.1.1 and A.1.2. From these tables, we can see that only two estimated
type I error rates of CCA are not within the CIs and these two type I error rates (one is
0.0126 for nominal level 0.01 in Table 1.1, and the other one is 0.05505 for nominal level
0.05 in Table S1) are very close to the upper bounds of the corresponding CIs, which
indicates that the four tests are all valid.
For power comparisons, we consider 10 traits and we assume that all causal variants
are rare. For each type of traits and each variance model, we consider different values of
heritability, different percentages of protective variants, and different percentages of causal
variants. In each of the simulation scenarios, the p-values of AWRR, Single-TOW and
CCA are estimated using 1,000 permutations (the p-values of WSRR are estimated by a
χ 2 distribution) and the power of all of the four tests is evaluated using 500 replicated
samples at a significance level of 0.05.
We first consider the first set of simulations for quantitative traits under variance
model 1. Figure 1.1 provides the power comparisons of the four tests (WSRR, AWRR,
CCA and Single-TOW) for the power as a function of heritability. This figure shows that
WSRR is the least powerful one and AWRR is the most powerful one. It is little
complicated to compare the power of Single-TOW with the power of CCA. When
genotypes impact on only one trait, Single-TOW is more powerful than CCA; otherwise,
CCA is more powerful than Single-TOW. Since Single-TOW only depends on the trait that
has the strongest association with genotypes, it is more favorable for Single-TOW when
genotypes impact on less traits. Power comparisons of the four tests for the power as a
function of percentage of protective variants are given by Figure 1.2. This figure shows
that, with the increasing of the percentage of protective variants, the power of WSRR
decreases while the power of the other three methods does not change. Other patterns of
the power comparisons are similar to those shown in Figure 1.1. The power comparisons
of the four tests for the power as a function of the percentage of causal variants are given
by Figure 1.3. As shown in this figure, with the increasing of the percentage of causal
variants, the power of WSRR increases while the power of the other three methods does
not change. WSRR is the least powerful one when the percentage of causal variants is small
(≤ 0.15), while WSRR is the most powerful test when the percentage of causal variants is
large (≥ 0.3). The patterns of the power comparisons of CCA, AWRR and Single-TOW are
similar to those shown in Figure 1.1.
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Under the first set of simulations, we also compare the powers of the four methods
for quantitative traits under variance model 2 and for qualitative traits under variance
models 1 and 2. These results are given in Figures B.1.1-B.1.9. For each type of traits, the
patterns of the power comparisons are similar under variance models 1 and 2. For
qualitative traits, CCA is consistently less powerful than Single-TOW and AWRR because
CCA is designed for quantitative traits. For qualitative traits, the powers of AWRR, SingleTOW, and CCA decrease with the increase of the percentage of protective variants,
although decrease not as fast as that of WSRR. As pointed out by Wu et al. (2011) and Sha
et al. (2012), the decrease in the powers of AWRR, Single-TOW, and CCA in the presence
of both risk and protective variants is due to the fact that protective variants lower MAFs
in cases and thus make observing rare variants in the cases more difficult. The larger
decrease in power of WSRR is additionally driven by the sensitivity to the direction of the
effect due to aggregation of genotypes.
Under the second set of simulations, we compare the powers of the four methods
for quantitative traits under variance model 1. Results are given in Figures S10-S12.
Comparing Figures B.1.10-B.1.12 with Figures 1.1-1.3, the patterns of the power
comparisons under the second set of simulations are very similar to that under the first set
of simulations. Under the second set of simulations, we also compare the powers of the
four methods for quantitative traits under variance model 2 and for qualitative traits under
variance models 1 and 2 (results are not shown). Results also show that the patterns of the
power comparisons under the second set of simulations are very similar to that under the
first set of simulations.
In summary, for all simulation scenarios, AWRR is consistently more powerful than
CCA and the power of WSRR increases with the increasing of the percentage of causal
variants or with the decreasing of the percentage of protective variants. For quantitative
traits, the powers of AWRR, CCA and Single-TOW are robust to the percentage of
protective variants and to the percentage of causal variants, while for qualitative traits, the
powers of AWRR, CCA and Single-TOW decrease with the increasing of the percentage
of protective variants and are relatively robust to the percentage of causal variants.
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Discussion
In this article, we proposed the AWRR method to perform joint analysis of multiple traits
in rare variant association studies based on the following reasons: (1) the development of
next-generation sequencing technology has made directly testing all rare variants feasible
and (2) there is increasing evidence showing that pleiotropy is a widespread phenomenon
in complex diseases and multiple related traits are usually measured in genetic association
studies of complex diseases. We used extensive simulation studies to compare the
performance of AWRR with CCA, WSRR and Single-TOW. Our results showed that
AWRR has correct type I error rates, is robust to the directions of the association of causal
variants for quantitative traits, and is robust to the percentage of causal variants. AWRR is
consistently more powerful than CCA. AWRR is more powerful than Single-TOW and
WSRR in most simulation scenarios.
Our simulation studies showed that the performance of each of AWRR, WSRR and
Single-TOW depends strongly upon the number of traits impacted by genetic variants, the
percentage of protective variants, and the percentage of causal variants. And no method
demonstrates consistently good power. To increase the robustness of the test, we can
combine AWRR, WSRR and Single-TOW aiming to have advantages of the three methods.
Let p AWRR , pWSRR and pSingle−TOW denote the p-values of AWRR, WSRR, and Single-TOW,
respectively.
Tcombined

The

combined

test
statistic
can
be
defined
as
= min { p AWRR , pWSRR , pSingle −TOW } . However, the performance of the combined test

needs further investigations.
In association studies based on unrelated individuals, it has been long recognized
that population stratification can seriously confound association results [Knowler et al.,
1988; Lander & Schork, 1994]. Several methods have been developed to control for
population stratification for association studies based on unrelated individuals. These
methods include GC approach [Devlin & Roeder, 1999; Devlin et al., 2001; Reich &
Goldstein, 2001], PC approach [Bauchet et al., 2007; Chen et al., 2003; Price et al., 2006;
Zhang et al., 2003; Zhu et al., 2002], and MLM approach [Kang et al., 2010; Zhang et al.,
2010]. Like most association tests based on unrelated individuals, AWRR subjects to bias
due to population stratification. To make AWRR robust to population stratification, we can
T
use the PC approach. Let Pi = ( pi1 ,…, piL ) denote the first L PCs of the genotypes at a set
of genomic markers for the i th individual. In step 3 of AWRR, we can use the residuals of
the regression
xi α + β T Pi + ε i to replace xi and use the residuals of the regression
=
yik α k + β kT Pi + ε ik to replace yik . The performance of using the PC approach to control for
=
population stratification in AWRR also needs further investigations.
The computation time required for running AWRR depends on the sample size, the
number of variants in the genomic region, the number of traits, and the number of
permutations. The running time of AWRR with 1000 permutations on the data set with
1000 individuals, 10 traits, and 100 variants in the genomic region on a laptop with 4 Intel
11

Cores @ 2.00GHz and 4 GB memory is no more than 0.5s. To perform genome-wide
studies, we can first select genomic regions that show evidence of association based on a
small number of permutations (e.g. 1,000), and then a large number of permutations are
used to test the selected regions.
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Tables and Figures
Table 1.1. The estimated type I error rates of four methods for quantitative traits under
variance model 1. 10,000 replicates are used. This set of simulations is based on Sgene1.
Sample size

𝛼𝛼 = 0.05

𝛼𝛼 = 0.01

500

1000

2000

CCA

0.0518

0.0519

0.04645

Single-TOW

0.04995

0.05255

0.0506

WSRR

0.0464

0.0506

0.0496

AWRR

0.0519

0.0527

0.0531

CCA

0.012

0.00845

0.0126

Single-TOW

0.0117

0.00965

0.012

WSRR

0.0081

0.009

0.0097

AWRR

0.01075

0.0097

0.01135
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Table 1.2. The estimated type I error rates of four methods for qualitative traits under
variance model 1. 10,000 replicates are used. This set of simulations is based on Sgene1.

Sample size

𝛼𝛼 = 0.05

𝛼𝛼 = 0.01

500

1000

2000

CCA

0.052

0.0527

0.04985

Single-TOW

0.0519

0.0534

0.05

WSRR

0.0502

0.0493

0.0487

AWRR

0.054

0.0505

0.05265

CCA

0.0101

0.01115

0.00955

Single-TOW

0.0109

0.01165

0.01115

WSRR

0.0106

0.0092

0.0106

AWRR

0.00955

0.00965

0.012
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Figure 1.1. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-TOW)
for the power as a function of heritability for quantitative traits under variance model 1.
The sample size is 1000 and ρ = 0.5 . The percentage of the causal variants is 0.1. All causal
variants are risk variants. The total number of traits is 10. This set of simulations is based
on Sgene1.

15

Figure 1.2. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-TOW)
for the power as a function of percentage of protective variants for quantitative traits under
variance model 1. The sample size is 1000, the percentage of causal variants is 0.2, the
total heritability is 0.03, and ρ = 0.5 . The total number of traits is 10. This set of
simulations is based on Sgene1.
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Figure 1.3. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-TOW)
for the power as a function of the percentage of causal variants for quantitative traits under
variance model 1. The sample size is 1000 and ρ = 0.5 , and the total heritability is 0.03.
All causal variants are risk variants. The total number of traits is 10. This set of simulations
is based on Sgene1.
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2 Chapter 2
Joint Analysis of Multiple Traits Using “Optimal” Maximum Heritability Test
Abstract: The joint analysis of multiple traits has recently become popular since it can
increase statistical power to detect genetic variants and there is increasing evidence
showing that pleiotropy is a widespread phenomenon in complex diseases. Currently, most
of existing methods use all of the traits for testing the association between multiple traits
and a single variant. However, those methods for association studies may lose power in the
presence of a large number of noise traits. In this paper, we propose an “optimal” maximum
heritability test (MHT-O) to test the association between multiple traits and a single variant.
MHT-O includes a procedure of deleting traits that have weak or no association with the
variant. Using extensive simulation studies, we compare the performance of MHT-O with
MHT, Trait-based Association Test uses Extended Simes procedure (TATES),
SUM_SCORE and MANOVA. Our results show that, in all of the simulation scenarios,
MHT-O is either the most powerful test or comparable to the most powerful test among
the five tests we compared.

Introduction
Increasing evidence shows that pleiotropy, the effect of one variant on multiple traits, is a
widespread phenomenon in complex diseases [Sivakumaran et al., 2011]. Furthermore, in
genetic association studies of complex diseases, multiple related traits are usually
measured. For example, hyperuricemia is usually present in patients with gout [Yang et al.,
2010]; coronary heart disease is predicted by cytokine interleukin-6, C-reactive protein,
interleukin-1, tumor necrosis factor-α and fibrinogen [Yudkin et al., 2000; Rifai and
Ridker, 2002]; and neuropsychiatric disorders depend on a range of overlapping clinical
characteristics [O'Reilly et al., 2012]. Although most published genome-wide association
studies (GWASs) analyze each of the related traits separately, joint analysis of multiple
traits may increase statistical power to detect genetic variants [Yang and Wang, 2012;
Solovieff et al., 2013; Stephens, 2013; Zhou and Stephens, 2014]. Thus, joint analysis of
multiple traits has recently become popular.
Several statistical methods have been developed for joint analysis of multiple traits.
These methods can be roughly divided into three groups: combining the univariate analysis
results, regression methods, and dimension reduction methods. For combining univariate
analysis results, one first conducts the univariate test by performing an association test for
each trait individually and then combines the univariate test statistics or combines the pvalues of the univariate tests [O'Brien, 1984; Yang et al., 2010; van der Sluis et al., 2013;
Kim et al., 2015]. Regression methods include mixed effect models [Korte et al., 2012;
Zhou and Stephens, 2014; Casale et al., 2015], generalized estimating equation (GEE)
methods [Zeger and Liang, 1986; Zhang et al., 2014], and reverse regression methods
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[O'Reilly et al., 2012; Yan et al., 2013]. Mixed effect models can account for relatedness,
population structure, and polygenic background effect, but it is computationally
challenging. The GEE methods, based on a marginal regression model, allow the variant
having different effect sizes and effect directions on different traits. These methods can
also accommodate covariates and different types of traits. Reverse regression methods take
genotypes as the response variable and multiple traits as independent predictors, therefore,
reverse regression models do not need to know the complex distributions of traits and can
be applied to a large number of mixed types of traits. Dimension reduction methods include
canonical correlation analysis (CCA) [Tang and Ferreira, 2012], principal components of
traits (PCT) [Aschard et al., 2014], and principal components of heritability (PCH) [Ott
and Rabinowitz, 1999; Lange et al., 2004; Klei et al., 2008; Zhou et al., 2015]. CCA is to
seek a linear combination of multiple variants and a linear combination of multiple traits
such that the correlation between the two linear combinations reaches its maximum. The
PCT methods are usually based on the first PC or first few PCs of the traits [Feng et al.,
2007; Klei et al., 2008]. However, as Aschard et al. [2014] showed that testing only the
first few PCs often has low power, whereas combining signals across all PCs can have
greater power. Nevertheless, it is not clear how many PCs are needed, and how robust these
methods are when there exists noise traits. PCH is to find a linear combination of multiple
traits such that this linear combination has the maximum heritability.
In this article, we first propose a maximum heritability test (MHT). Based on MHT,
we develop an “optimal” maximum heritability test (MHT-O) to test the association
between multiple traits and a single variant. In each step of MHT-O, we delete one trait
that has the weakest association with the variant. Then, we find the optimal number of traits
and use MHT to test the association between the optimal number of traits and the variant.
Using extensive simulation studies, we compare the performance of MHT-O with MHT,
Trait-based Association Test uses Extended Simes procedure (TATES) [van der Sluis et
al., 2013], SUM_SCORE and MANOVA [Yang and Wang, 2012]. Our results show that,
in all of the simulation scenarios, MHT-O is either the most powerful test or comparable
to the most powerful test among the five tests we compared.
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Methods
We consider a sample with n unrelated individuals. Each individual has K (potentially
T
correlated) traits and has been genotyped at one variant. Let Y = (Y1 ,…,YK ) denote the
random vector of K traits and X denote the random variable of the genotype score at a
T
variant. Let yi = ( yi1 ,…, yiK ) denote the values of K traits and xi denote the genotype
score of the i th individual, where xi is the number of minor alleles that the i th individual
has at the variant. We can consider that y1 ,…, yn is a random sample from Y and x1 ,…, xn
is a random sample from X .
Now, let us consider linear models
=
Yk α k + β k X + ε k ( k = 1,…, K ).

(1)

We partition the total phenotypic covariance of Y as V=
VG + VR [Falconer and Mackay,
P
T
=
=
1996]; VG var
[ β1 X ,…, β K X ] var ( X ) ββ is the genetic variance due to the genotype
β ( β1 ,…, β K ) ; VR = var [ε1 ,…, ε K ] is the residual covariance after
scores X , where =
T

removing the genetic effect. var ( X ) can be estimated by
and VR can be estimated from the linear models

1 n
1 n
2
x
=
x
x
−
,
(
)
∑ xi . β
∑ i
n i =1
n i =1

=
yik α k + β k xi + ε ik ( k = 1,…, K ; i = 1,…, n ).

β k is estimated by the least square estimator. Let rik denote the estimates of residuals ε ik .
1 n
th
Then, the ( j, k ) element of VR is estimated by ∑ rij rik .
n i =1
K

Let us consider a linear combination of Y , wT Y = ∑ wkYk , where w = ( w1 ,…, wK ) .
k =1

The heritability of w Y can be written as
T

hw2 =

wTVG w
.
wTVP w

If we define W = VP1 2 w , we can write hw2 as
−

1

−

1

W TVP 2VGVP 2W W TVW
h =
= T
,
W TW
W W
2
w

20

T

−

1
2

−

1
2

where V = VP VGVP . The heritability of wT Y depends on w and we can find a linear
combination of wT Y that has the largest heritability among all linear combinations of Y .
We define the maximum heritability as the test statistic to test the association between these
K traits and the variant. We denote this test as maximum heritability test (MHT). The
MHT statistic can be written as
T −1
2
=
TMHT max
=
λmax (=
VGVP−1 ) var ( X ) λmax ( ββ
=
VP ) var ( X ) β TVP−1β ,
w hw

where λmax ( A) denotes the largest eigenvalue of matrix A .
However, the test statistic TMHT may lose power in the presence of a large number
of noise traits. Therefore, we propose an “optimal” maximum heritability test (MHT-O) to
test the association between multiple traits and the variant. MHT-O includes a procedure
of deleting traits that have weak or no association with the variant. It has the following
steps:
Step 1. Given traits Y = (Y1 ,…,YK ) , initialize r = K and Y ( r ) = Y . Denote TMHT , r as
r
TMHT based on Y ( ) .

(r)
−i
Step 2. Denote TMHT
with the i th trait deleted for i = 1,…, r ;
, r as TMHT based on Y
( r −1)
−i
−I
denote I = arg max i TMHT
denote Y ( r ) with
, r and TMHT , r −1 = TMHT , r . Let Y
the I th trait deleted and update r= r − 1 .

Step 3. Repeat step 2 until r = 1 .
Denote pr as the p-value of TMHT , r . The test statistic of MHT-O is defined as
TMHT −O = min1 ≤ r ≤ K pr .

We use a permutation test to evaluate the p-value of TMHT −O . Intuitively, two layers
of permutations are needed to estimate pr and the overall p-value for the test statistic
TMHT −O . Ge et al. [Ge et al., 2003]proposed that one layer of permutation can be used to
estimate these p-values. We use the permutation procedure of Ge et al. to estimate pr and
the overall p-value for the test statistic TMHT −O . In details, we randomly shuffle the
(b)
genotypes in each permutation. Suppose we perform B times of permutations. Let TMHT
,r
th
denote the value of TMHT , r based on the b permuted data, where b = 0 represents the

(b)
(b)
original data. Then, we transfer TMHT
by
, r to pr
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(b)

pr =

{

}.

(d )
(b)
# d : TMHT
0,1,…, B
, r > TMHT , r for d =

B

Let p (b ) = min1 ≤ r ≤ K pr(b ) , Then, the p-value of TMHT −O is given by
#{b : p ( b ) < p (0) for=
b 1,2,…, B}
.
B

The R code of MHT-O is available at
http://www.math.mtu.edu/~shuzhang/software.html.
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Comparison of Methods
We compare our proposed method with MHT, TATES [van der Sluis et al., 2013],
MANOVA [Yang and Wang, 2012], and SUM_SCORE. TATES combines p-values
obtained in a standard univariate GAWS to acquire one trait-based p-value, while
correcting for correlations between components. SUM_SCORE performs an association
test for each trait individually to obtain the univariate score test statistic for each trait. Then,
the test statistic of SUM_SCORE is the summation of the univariate score test statistics.
We use asymptotic distributions to evaluate the p-values of SUM_SCORE, TATES and
MANOVA.
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Simulation Studies
To evaluate the type I error rates and powers of MHT and MHT-O, we generate genotypes
according to minor allele frequency (MAF) and assume Hardy Weinberg equilibrium.
Then, we generate K traits by the factor model [van der Sluis et al., 2013; Aschard et al.,
2014]
y = λ x + cγf + 1 − c 2 × ε ,

(1)

λ ( λ1 ,…, λK ) is
where y = ( y1 ,…, y K ) ; x is the genotype score at the variant of interest; =
the vector of effect sizes of the genetic variant on the K traits;
T
f = ( f1 ,…, f R ) ~ MVN ( 0, Σ ) , Σ= (1 − ρ ) I + ρ A , A is a matrix with elements of 1, I is the
identity matrix, and ρ is the correlation between factors; γ is a K by R matrix; c is a
T

constant number; and =
ε ( ε1 ,…, ε K ) is a vector of
independent, and ε k ~ N ( 0,1) for k = 1,…, K .
T

residuals, and ε1 ,…, ε K are

Based on equation (1), we consider five models:
Model 1: There is only one factor and genotypes impact on all traits with the same effect
T
T
λ ( β ,…, β ) , and γ= (1,…,1) .
size. That is, R = 1 , =
Model 2: There are five factors and genotypes impact on one factor. That is, R = 5 ,
T
T
λ=
( 0,…,0, β ,…, β ) , and γ = diag ( D1 , D2 , D3 , D4 , D5 ) , where Di = (1,…,1) for i = 1,…,5 .
Model 3: There are two factors and genotypes impact on one factor. That is, R = 2 ,
T
T
λ=
( 0,…,0, β ,…, β ) , and γ = diag ( D1 , D2 ) , where Di = (1,…,1) for i = 1,2 .
Model 4: There are five factors and genotypes impact on one trait. That is, R = 5 ,
T
T
λ= ( 0,…,0, β ) , and γ = diag ( D1 , D2 , D3 , D4 , D5 ) , where Di = (1,…,1) for i = 1,…,5 .
Model 5: There is only one factor and genotypes impact on one trait. That is, R = 1 ,
T
T
λ= ( 0,…,0, β ) , and γ= (1,…,1) .
To evaluate type I error rates of MHT and MHT-O, we let β = 0 . To evaluate
powers, we let β > 0 . In the simulation studies for evaluation of type I error rates and
powers, we set MAF = 0.3 and ρ = 0.2 .
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Simulation Results
To evaluate the type I error rates of the two proposed tests (MHT and MHT-O), we consider
20 quantitative traits. We also consider different sample sizes, different significance levels,
and different models. In each simulation scenario, the p-values of MHT and MHT-O are
estimated by 1,000 permutations and the type I error rates of the two tests are evaluated
using 10,000 replicated samples. For 10,000 replicated samples, the 95% confidence
intervals (CIs) for estimated type I error rates of nominal levels 0.05 and 0.01 are (0.046,
0.054) and (0.008, 0.012), respectively (see end of this chapter). The estimated type I error
rates of the two tests are summarized in Table 2.1. From this table, we can see that 58 out
of 60 (greater than 95%) estimated type I error rates are within the 95% CIs and the two
estimated type I error rates (0.05415 and 0.0126) not within the 95% CIs are very close to
the bound of the corresponding 95% CI, which indicates that the two tests are all valid.
For power comparisons, we consider different values of the effect size, different
models, and different numbers of traits. Sample size is 1,000 for all the cases. In each of
the simulation scenarios, the p-values of MHT and MHT-O are estimated using 1,000
permutations and the p-values of SUM_SCORE, TATES and MANOVA are estimated
using their asymptotic distributions. The powers of all of the five tests are evaluated using
500 replicated samples at a significance level of 0.05.
Figure 2.1 gives the power comparisons of the five tests (SUM_SCORE, TATES,
MHT, MHT-O and MANOVA) for the power as a function of the effect size based on the
five models for 20 traits. This figure shows that (1) MHT-O is either the most powerful
one (genotypes directly impact on a single trait: models 4-5) or comparable to the most
powerful one (genotypes directly impact on all or a portion of the traits: models 1-3) among
the five tests; (2) MHT and MANOVA have very similar powers; (3) MHT and MANOVA
are much less powerful than other methods when genotypes directly impact on only a
portion of the traits (models 2-3); (4) TATES is much less powerful than other methods
when genotypes directly impact on all the traits (model 1); and (5) SUM_SCORE is much
less powerful than other methods when genotypes directly impact on a single trait (models
4-5).
Power comparisons of the five tests for 30 and 40 traits are given in Figures 2.2 and
2.3, respectively. The patterns of power comparisons for 30 and 40 traits (Figures 2.2 and
2.3) are similar to that for 20 traits (Figure 2.1). We also give power comparisons of the
five tests using a significance level of 5 × 10−8 with 108 permutations and 500 replicates for
20 traits under model 1 (Figure B.2.1). Figure B.2.1 shows that the patterns of the power
comparisons using significance level 5 × 10−8 are similar to that using a significance level
of 0.05 in Figure 2.1 (model 1). In summary, MHT-O is either the most powerful test or
comparable to the most powerful test among all the tests we compared. Therefore, our
MHT-O is a robust test to a variety of models.
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Discussion
We propose MHT-O to perform joint analysis of multiple traits in association studies based
on the following reasons: (1) multiple related traits are usually measured in genetic
association studies of complex diseases; (2) there is increasing evidence showing that
pleiotropy is a widespread phenomenon in complex diseases; and (3) the power of existing
methods decreases in the presence of non-associated traits. The proposed MHT-O includes
a procedure of deleting traits that have weak or no association with the variant. Therefore,
it can be robust to the existence and the number of non-associated traits. By deleting one
trait that has the weakest association with the variant in each step, MHT-O can maintain
high power in the presence of a large number of non-associated traits. This feature is
essentially important when there exist a large number of correlated traits but there are no
guidelines to select relevant traits. Our results show that MHT-O has correct type I error
rates and is either the most powerful test or comparable to the most powerful test among
the five tests we compared. No other methods in the simulation studies show consistent
good performance.
Due to the allelic heterogeneity and the extreme rarity of individual variants in rare
variant association studies, the variant-by-variant methods for common variant association
studies may not be optimal [Li and Leal, 2008]. It has been shown by recent studies that
complex diseases are caused by both common and rare variants [Pritchard, 2001; Pritchard
and Cox, 2002; Walsh and King, 2007; Bodmer and Bonilla, 2008; Stratton and Rahman,
2008; Kang et al., 2010; Teer and Mullikin, 2010]. Statistical methods including burden
tests [Morgenthaler and Thilly, 2007; Li and Leal, 2008; Madsen and Browning, 2009;
Price et al., 2010; Zawistowski et al., 2010], quadratic tests [Neale et al., 2011; Wu et al.,
2011; Sha et al., 2012], and combined tests [Lee et al., 2012; Derkach et al., 2013; Sha and
Zhang, 2014] have been developed for rare variant association studies with a single trait.
Currently, there are limited researches on rare variant association studies for joint analysis
of multiple traits [Casale et al., 2015; Wang et al., 2015]. MHT-O can be extended to rare
variant association studies by extending equation (1) to include multiple variants. MHT-O
can also be extended to family-based studies by extending equation (1) to mixed linear
model. However, the performance of MHT-O in rare variant association studies and in
family-based association studies needs further investigation.
The fact that population stratification can seriously confound association results has
been long recognized in association studies based on unrelated individuals [Knowler et al.,
1988; Lander and Schork, 1994]. Several methods to control for population stratification
have been developed for association studies based on unrelated individuals. These methods
include principal component (PC) approach [Zhu et al., 2002; Chen et al., 2003; Zhang et
al., 2003; Price et al., 2006; Bauchet et al., 2007], genomic control (GC) approach [Devlin
and Roeder, 1999; Devlin et al., 2001; Reich and Goldstein, 2001], and mixed linear model
(MLM) approach [Kang et al., 2010; Zhang et al., 2010]. Like most association tests based
on unrelated individuals, MHT-O subjects to bias due to population stratification. To make
MHT-O robust to population stratification, we can use the PC approach. Let
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Pi = ( pi1 , …, piL ) denote the first L PCs of the genotypes at a set of genomic markers for
T

the i th individual. Let

yik*

and xi* denote the residuals of the regressions

=
xi α 0 + α T Pi + ε i , respectively.
yik = α 0 k + α kT Pi + ε ik and the residuals of the regression

Using yik* and xi* to replace yik and xi , we can make MHT-O robust to population
stratification. However, the performance of using the PC approach to control for population
stratification in MHT-O needs further investigations.
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Confidence Interval
Let p denote the p-value of the test and denote a random variable
1,
0,

ξ =

p ≤α
,
p >α

where α is the significance level. Then, Pr (ξ= 1=
) α and Pr (ξ = 0 )= 1 − α because p
follows a uniform distribution between 0 and 1 under the null hypothesis. Suppose there
are R replicates. Let ξi denote the value of ξ for the i th replicate, where i = 1,…, R . Then,
1 R
∑ ξi that asymptotically follows a normal
R i =1
 α (1 − α ) 
N α ,
.
Thus,

R



the estimated type I error rate is given by ξ =
distribution



ξ −α
Pr 
≤ 1.96  = Pr α − 1.96 α (1 − α ) R ≤ ξ ≤ α + 1.96 α (1 − α ) R = 0.95 .
 α (1 − α ) R




)

(

We define

(α − 1.96

α (1 − α ) R ,α + 1.96 α (1 − α ) R

)

as the 95% confidence

interval for the estimated type I error rate for the nominal level α .
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Tables and Figures
Table 2.1. The estimated type I error rates of MHT and MHT-O. 10,000 replicates are used.
Sample size

Model 1

𝛼𝛼 = 0.05
𝛼𝛼 = 0.01

Model 2

𝛼𝛼 = 0.05
𝛼𝛼 = 0.01

Model 3

𝛼𝛼 = 0.05
𝛼𝛼 = 0.01

Model 4

𝛼𝛼 = 0.05
𝛼𝛼 = 0.01

Model 5

𝛼𝛼 = 0.05
𝛼𝛼 = 0.01

500

1000

2000

MHT-O

0.05415

0.0494

0.04875

MHT

0.05235

0.05005

0.0501

MHT-O

0.01035

0.012

0.0091

MHT

0.00985

0.01195

0.01105

MHT-O

0.0499

0.0515

0.0526

MHT

0.04815

0.05175

0.05285

MHT-O

0.01045

0.01175

0.01135

MHT

0.0117

0.0118

0.0126

MHT-O

0.05015

0.0517

0.05315

MHT

0.04875

0.0507

0.0529

MHT-O

0.00995

0.0109

0.012

MHT

0.0104

0.01035

0.012

MHT-O

0.04815

0.0516

0.05255

MHT

0.04875

0.05275

0.0507

MHT-O

0.00975

0.0118

0.00975

MHT

0.00855

0.012

0.01

MHT-O

0.04865

0.0499

0.04975

MHT

0.05095

0.05195

0.04755

MHT-O

0.012

0.0119

0.00915

MHT

0.01075

0.01115

0.0096
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Figure 2.1. Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-O
and MANOVA) for the power as a function of the effect size. Sample size is 1000. Total
number of traits is 20.
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Figure 2.2. Power comparisons of the five tests (SUM_ SCORE, TATES, MHT, MHT-O
and MANOVA) for the power as a function of the effect size. Sample size is 1000. Total
number of traits is 30.
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Figure 2.3. Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-O
and MANOVA) for the power as a function of the effect size. Sample size is 1000. Total
number of traits is 40.
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Chapter 3
Testing an optimally weighted combination of common and/or rare variants with
multiple traits
Joint analysis of multiple traits has recently become popular since it can increase statistical
power to detect genetic variants and there is increasing evidence showing that pleiotropy
is a widespread phenomenon in complex diseases. Currently, most of existing methods test
the association between multiple traits and a single common variant. However, the variantby-variant methods for common variant association studies may not be optimal for rare
variant association studies due to the allelic heterogeneity as well as the extreme rarity of
individual variants. In this article, we developed a statistical method by testing an optimally
weighted combination of variants with multiple traits (TOWmuT) to test the association
between multiple traits and a weighted combination of variants (rare and/or common) in a
genomic region. TOWmuT is robust to the directions of effects of causal variants and is
applicable to different types of traits. Using extensive simulation studies, we compared the
performance of TOWmuT with the following five existing methods: gene association with
multiple traits (GAMuT), multiple sequence kernel association test (MSKAT), adaptive
weighting reverse regression (AWRR), single-TOW, and MANOVA. Our results showed
that, in all of the simulation scenarios, TOWmuT has correct type I error rates and is
consistently more powerful than the other five tests. We also illustrated the usefulness of
TOWmuT by analyzing a whole-genome genotyping data from a lung function study.

Introduction
Many large cohort studies collected many correlated traits that can reflect underlying
mechanism of complex diseases. For example, the UK10K cohort study collected 64
correlated phenotypic traits [The UK10K Consortium et al., 2015]. Usually complex
diseases are characterized by multiple endophenotypes. For example, hypertension can be
characterized by systolic and diastolic blood pressure [Newton-Cheh et al., 2009];
metabolic syndrome is evaluated by four component traits: high-density lipoprotein (HDL)
cholesterol, plasma glucose and Type 2 diabetes, abdominal obesity, and diastolic blood
pressure [Zabaneh and Balding, 2010]; and schizophrenia can be diagnosed by eight
neurocognitive domains [Gur et al., 2007]. Multiple correlated traits can be influenced by
a gene simultaneously. Therefore, by joint analysis of multiple traits, we can not only gain
more statistical power to detect pleiotropic variants [Yang and Wang, 2012; Solovieff et
al., 2013; Stephens, 2013; Zhou and Stephens, 2014; Zhu et al., 2015a; Liang et al., 2016;
Wang et al., 2016a; Wang et al., 2016b], but also can be important to understand the genetic
architecture of the disease of interest [Aschard et al., 2014].
Several statistical methods have been developed for testing the association between
multiple traits and a single common variant. These methods can be roughly divided into
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three groups: dimension reduction methods [Klei et al., 2008; Ferreira and Purcell, 2009;
Aschard et al., 2014; Wang et al., 2016a], regression methods [Korte et al., 2012; O'Reilly
et al., 2012; Zhang et al., 2014], and combining test statistics from univariate analysis
[O'Brien, 1984; Yang et al., 2010; van der Sluis et al., 2013; Kim et al., 2015; Zhu et al.,
2015b; Liang et al., 2016]. However, due to the allelic heterogeneity as well as the extreme
rarity of rare variants [Li and Leal, 2008], the variant-by-variant methods for common
variant association studies may not be optimal for rare variant association studies. Recent
studies show that complex diseases are caused by both common and rare variants
[Pritchard, 2001; Pritchard and Cox, 2002; Walsh and King, 2007; Bodmer and Bonilla,
2008; Stratton and Rahman, 2008; Kang et al., 2010; Teer and Mullikin, 2010]. Nextgeneration sequencing technology allows sequencing of the whole genome of large groups
of individuals, and thus makes rare variant association studies feasible [Andres et al., 2007;
Metzker, 2010]. Recently, statistical methods for rare variant association studies with a
single trait have been developed by summarizing genotype information from multiple
variants. These methods include burden tests [Morgenthaler and Thilly, 2007; Li and Leal,
2008; Madsen and Browning, 2009; Price et al., 2010; Zawistowski et al., 2010], quadratic
tests [Neale et al., 2011; Wu et al., 2011; Sha et al., 2012; Yang et al., 2017], and combined
tests [Derkach et al., 2013; Lee et al., 2013; Sha and Zhang, 2014; Greco et al., 2015].
As we pointed out above, it is essential to develop statistical methods to test the
association between multiple traits and multiple variants (common and/or rare variants).
Very recently, a few statistical methods for this purpose are appeared [Casale et al., 2015;
Wang et al., 2015; Broadaway et al., 2016; Sun et al., 2016; Wang et al., 2016b; Wu and
Pankow, 2016]. Casale et al. [2015] proposed a set-based association test based on the
linear mixed-model. This method enables jointly analyzing multiple correlated traits in rare
variant association studies while accounting for population structure and relatedness. Wang
et al. [2015] proposed a multivariate functional linear model approach to test association
between multiple traits and rare variants in a genomic region. In this approach, the genetic
effects of variants are treated as smooth functions of genomic positions of these variants.
Gene association with multiple traits (GAMuT) proposed by Broadaway et al. [2016]
provide a nonparametric test of independence between a set of traits and a set of genetic
variants. This method compares the similarities of multiple traits with the similarities of
genotypes at variants in a genomic region. Multivariate Rare-Variant Association Test
(MURAT) proposed by Sun et al. [2016] tests association between multiple correlated
quantitative traits and a set of rare variants based on a linear mixed model. This method
assumes that the effects of the variants follow a multivariate normal distribution with a
zero mean and a specific covariance structure. Wu and Pankow [2016] extended the
commonly used sequence kernel association test (SKAT) [Wu et al., 2011] for a single trait
to multiple traits and proposed multiple sequence kernel association test (MSKAT). Wang
et al. [2016b] proposed an adaptive weighting reverse regression (AWRR) method. This
method uses the score test based on the reverse regression, in which the summation of
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adaptively weighted genotypes is treated as the response variable and multiple traits are
treated as independent variables.
In this article, we developed a new statistical method by testing an optimally
weighted combination of variants with multiple traits (TOWmuT) to test the association
between multiple traits and a weighted combination of variants (rare and/or common) in a
genomic region. TOWmuT is based on the score test under a linear model, in which the
weighted combination of variants is treated as the response variable and multiple traits
including covariates are treated as independent variables. The statistic of TOWmuT is the
maximum of the score test statistic over weights. The weights at which the score test
statistic reaches its maximum are called the optimal weights. TOWmuT is applicable to
different types of traits and can include covariates. Using extensive simulation studies, we
compared the performance of TOWmuT with single-TOW [Sha et al., 2012], GAMuT
[Broadaway et al., 2016], MSKAT [Wu and Pankow, 2016], AWRR [Wang et al., 2016b]
and MANOVA [Yang and Wang, 2012]. Our results showed that, in all the simulation
scenarios, TOWmuT is either the most powerful test or comparable to the most powerful
test among the six tests. We also illustrated the usefulness of TOWmuT by analyzing a real
whole-genome genotyping data from a lung function study.
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Methods
We consider a sample with n unrelated individuals. Each individual has K potentially
correlated quantitative or qualitative traits (1 for cases and 0 for controls for a qualitative
trait) and has been genotyped at M variants in a genomic region. Let yik* denote the k th
trait value of the i th individual and xim* denote the genotype score of the i th individual at
the m th variant, where xim* is the number of minor alleles that the i th individual carries at
*
the m th variant. We first centralize yik* and xim* as y=
yik* − yk and x=
xim
− xm , where
ik
im
1 n *
1 n
T
T
y
and xm = ∑ i =1 xim* . Let Yi = ( yi1 ,…, yiK ) , X i = ( xi1 ,…, xiM ) ,
∑
i =1 ik
n
n
T
T
Y = (Y1 ,…, Yn ) , and X = ( X 1 ,…, X n ) . For the i th individual, we consider a linear
yk =

combination of the variants xi = ∑ m =1 wm xim , where w = ( w1 ,…, wM ) are weights and their
values will be decided later.
M

T

Without covariates
We first describe our method without covariates. Consider the linear model
𝑥𝑥𝑖𝑖 = 𝛽𝛽1 𝑦𝑦𝑖𝑖1 + ⋯ + 𝛽𝛽𝐾𝐾 𝑦𝑦𝑖𝑖𝑖𝑖 + 𝜀𝜀𝑖𝑖 .

(1)

Tscore = U TV −1U σ 2 ,

(2)

The score test statistic to test the null hypothesis 𝐻𝐻0 : 𝛽𝛽1 = ⋯ = 𝛽𝛽𝐾𝐾 = 0 is given by
where
=
U

=
xY
∑
n

i =1 i i

T
Y=
Xw , V

=
YY
∑
n

i =1 i i

T

and σ 2
Y T Y ,=

1 n 2 1 T T
=
∑ xi n w X Xw . We use
n i =1

1
1

A = diag  X T X  to replace X T X . Then σ 2 becomes σ 02 = wT Aw and Tscore becomes
n
n

wT X T Y (Y T Y ) Y T Xw
−1

0
score

T

( w) =

wT Aw

. We define the test statistic of TOWmuT as
0
TTOWmuT = max w Tsco
re ( w ) .

(

(3)

)

0
=
λmax A−1 2 X T Y (Y T Y ) Y T XA−1 2 , where λmax
Let W = A1 2 w ,=
then TTOWmuT max
W Tscore (W )
−1

indicates the largest eigenvalue of a matrix. Let W 0 denote the eigenvector of
−1
A−1 2 X T Y (Y T Y ) Y T XA−1 2 corresponding to the largest eigenvalue, then w0 = A−1 2W 0 is the
optimal weights. Actually, we do not need to calculate w0 in order to calculate TTOWmuT . If
we let C = XA−1 X T , then
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(

)

(

)

TTOWmuT = λmax A−1 2 X T Y (Y T Y ) Y T XA−1 2 = λmax (Y T Y ) Y T CY .
−1

−1

(4)

We use a permutation test to evaluate the p-value of TTOWmuT . In details, we randomly

shuffle the traits in each permutation. Note that C and (Y T Y ) do not change in each
−1

(b)
permutation. Suppose that we perform B times of permutations. Let TTOWmuT
denote the
th
value of TTOWmuT based on the b permuted data, where b = 0 represents the original data.
Then, the p-value of TTOWmuT is given by

{

}.

(0)
(b)
≥ TTOWmuT
for b = 1,…, B
# b : TTOWmuT

B

(5)

With covariates
Assume that there are p covariates and zi1 ,…, zip denote the p covariates of the i th
individual. Consider the linear model
𝑥𝑥𝑖𝑖 = 𝛼𝛼0 + 𝛼𝛼1 𝑧𝑧𝑖𝑖1 + ⋯ + 𝛼𝛼𝑝𝑝 𝑧𝑧𝑖𝑖𝑖𝑖 + 𝛽𝛽1 𝑦𝑦𝑖𝑖1 + ⋯ + 𝛽𝛽𝐾𝐾 𝑦𝑦𝑖𝑖𝑖𝑖 + 𝜀𝜀𝑖𝑖 .

(6)

In the end of this chapter, we showed that under model (6), the score test statistic with
covariates to test the null hypothesis H 0 : β1 = L = β K = 0 is given by
𝑐𝑐
� 𝑇𝑇 𝑉𝑉� 𝑈𝑈
�/𝜎𝜎� 2 ,
= 𝑈𝑈
𝑇𝑇𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

(7)

yik = α 0 k + α1k zi1 + ... + α pk zip + ε ik and xim = α 0 m + α1m zi1 + ... + α pm zip + τ im .

(8)

� = 𝑌𝑌� 𝑇𝑇 𝑋𝑋�𝑤𝑤 , 𝑉𝑉� = 𝑌𝑌� 𝑇𝑇 𝑌𝑌� , 𝜎𝜎� 2 = 1 𝑤𝑤 𝑇𝑇 𝑋𝑋� 𝑇𝑇 𝑋𝑋�𝑤𝑤 , 𝑋𝑋� = (𝑥𝑥�𝑖𝑖𝑖𝑖 ) , 𝑌𝑌� = (𝑦𝑦�𝑖𝑖𝑖𝑖 ) , 𝑦𝑦�𝑖𝑖𝑖𝑖 and 𝑥𝑥�𝑖𝑖𝑖𝑖
where 𝑈𝑈
𝑛𝑛
denote the residuals of yik and xim under

We can see the score test statistic with covariates
c
Tscore
= Tscore .

(9)

That is, replacing yik and xim by their residuals 𝑦𝑦�𝑖𝑖𝑖𝑖 and 𝑥𝑥�𝑖𝑖𝑖𝑖 in the score test statistic
c
without covariates Tscore , it becomes the score test statistic with covariates Tscore
.
Therefore, we define TOWmuT statistic with covariates as
c
TTOWmuT
= TTOWmuT .
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(10)

In summary, to apply TOWmuT with covariates, we adjust both trait value yik and
genotypic score xim for the covariates by applying linear regressions in (8) and apply
TOWmuT without covariates to the residuals 𝑦𝑦�𝑖𝑖𝑖𝑖 and 𝑥𝑥�𝑖𝑖𝑖𝑖 .

Comparison of Methods

We compare the performance of our method with the following methods: Multivariate
Analysis of Variance (MANOVA) [Liang et al., 2016], MSKAT [Wu and Pankow, 2016],
GAMuT [Broadaway et al., 2016], AWRR [Wang et al., 2016b] and single-TOW [Sha et
al., 2012]. Here we briefly introduce each of those methods using the notations in the
method section.
MANOVA: Consider a multivariate multiple linear regression model:=
Y Xβ +ε
, where Y denotes the n × K matrix of phenotypes; X denotes the n × M matrix of
genotypes; β is a M × K matrix of coefficients; ε is the n × K matrix of random errors
with each row of ε to be i.i.d. MVN ( 0, Σ ) , where Σ is the covariance matrix of ε . To
test H 0 : β = 0 , the likelihood ratio test is equivalent to the Wilk’s Lambda test statistic of
Σˆ 0
 E 
= −n log 
MANOVA, that is, −2 log Λ = 2 l βˆ , Σˆ − l 0, Σˆ 0 = n log
 . Here
+
E
H
Σˆ


Λ denote the ratio of the likelihood function under H 0 to the likelihood function under
H
,
is
the
log-likelihood
function,
and
l ( β , Σ)
H = βˆ T ( X T X ) βˆ

( ( ) ( ))

1

−1
=
E Y T Y − βˆ T ( X T X ) βˆ , where βˆ = ( X T X ) X T Y is the maximum likelihood estimator

(MLE) of β , and

denotes the determinant of a matrix. The test statistic has an

asymptotic χ K2 distribution.
MSKAT: MSKAT extends the commonly used SKAT [Wu et al., 2011] for single
trait analysis to test for the joint association of rare variant set with multiple continuous
traits.
GAMuT: GAMuT compares the similarity in multivariate phenotypes to the
similarity in rare-variant genotypes in a genomic region by a machine-learning framework
called kernel distance covariance.
AWRR: by collapsing genotypes using adaptive weights, AWRR uses the score
test to test association based on the reverse regression, in which collapsed genotypes are
treated as the response variable and multiple traits are treated as independent variables.
k
Single-TOW: Let TTOW
denote the test statistic of TOW to test the association
between the k th trait and the genotypes at the variants in a genomic region. The test
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statistic of single-TOW is given by Tsingle−TOW = min1≤k ≤ K pk , where pk is the p-value of
k
TTOW
for k = 1, …, K . The p-value of
procedure.

Tsingle−TOW is estimated using a permutation
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Simulations
In our simulation studies, we use the empirical Mini-Exome genotype data provided by the
genetic analysis workshop 17 (GAW17) to generate genotypes. This dataset contains
genotypes of 697 unrelated individuals on 3205 genes. We choose four genes: ELAVL4
(gene1), MSH4 (gene2), PDE4B (gene3), and ADAMTS4 (gene4) with 10, 20, 30, and 40
variants, respectively. Then, we merge the four genes to form a super gene (Sgene) with
100 variants. In our simulation studies, we generate genotypes based on the genotypes of
697 individuals in the Sgene because the distribution of the minor allele frequencies
(MAFs) in the Sgene can represent the distribution of MAFs in all of the 3205 genes [Sha
et., 2012]. To generate a qualitative disease affection status, we use a liability threshold
model based on a continuous phenotype (quantitative trait). An individual is defined as
affected if the individual’s phenotype is at least one standard deviation larger than the
phenotypic mean. This yields a prevalence of 16% for the simulated disease in the general
population. In the following, we describe how to generate a quantitative trait.
We consider that all causal variants are rare (MAF < 0.01). We randomly choose
nc rare variants as causal variants, where nc is determined by the percentage of causal
variants among rare variants. We use nr and n p to denote the number of risk rare variants
nc . Let xqir and x jip denote the
and protective rare variants, respectively, where nr + n p =

genotypic scores of the q th risk rare variant and the j th protective rare variant for the i th
individual, respectively. We assume that genotypes impact on L traits. Let h and hl
denote the heritability of all the nc rare causal variants for the L traits and the l th trait
among the L traits, respectively. We generate L random numbers t1 ,…, tL from a uniform
distribution between 0 and 1. Then, the heritability of l th trait among the L traits is
hl = htl

L

∑t
l =1

l

. Given the heritability of the l th trait hl , we generate nc random numbers

r1 ,…, rnc from a uniform distribution between 0 and 1. The heritability of the m th causal

variant for the l th trait is given by hl( m ) = hl rm

nc

∑r
j =1

j

.

In our simulation studies, we consider two covariates Z1 and Z 2 , where Z1 is a
continuous covariate generated from a standard normal distribution, and Z 2 is a binary
covariate taking values 0 and 1 with a probability of 0.5. We generate K traits by
considering the factor model [van der Sluis et al., 2013; Aschard et al., 2014; Wang et al.,
2016a]
y =( 0.5Z1 + 0.5Z 2 ) e + ( λ1 ,…, λK ) + cγf + 1 − c 2 × ε ,
T

40

(11)

λ
where y = ( y1 ,…, y K ) ; e = (1,…,1) ; =
T

f = ( f1 ,…, f R ) ~ MVN ( 0, Σ ) , Σ=
T

T

( λ1 ,…, λK ) is the vector involved genotypes;

(1 − ρ ) I + ρ A ,

A is a matrix with elements of 1, I is the

identity matrix, and ρ is the correlation between f i and f j ; R is the number of factors;
γ is a K by R matrix; c is a constant number; =
ε

T
(ε1 ,…, ε K ) is a vector of residuals;

and ε1 ,…, ε K are independent, ε k ~ N ( 0,1) for k = 1,…, K .

We consider the following six models with different number of factors and different
number of traits affected by genotypes. In these models, the within-factor correlation is c 2
and the between-factor correlation is ρ1 = ρ c 2 .
Model 1: There is only one factor and genotypes impact on 6 traits with the same effect
T
size. This is equivalent to set R = 1 and γ= (1,…,1) . In details,
np
nr

r r
p p
2
0.5Z1 + 0.5Z 2 + ∑ β kq xq − ∑ β kj x j + cf1 + 1 − c × ε k , 1 ≤ k ≤ 6
yk = 
.
=
q 1 =j 1

2
k >6
0.5Z1 + 0.5Z 2 + cf1 + 1 − c × ε k ,

(12)

Model 2: There are five factors and genotypes impact on 6 traits. We set R = 5 and
T
γ = diag ( D1 , D2 , D3 , D4 , D5 ) , where Di = (1,…,1) for i = 1,…,5 . In details,
np
nr

2
r r
p p
0.5Z1 + 0.5Z 2 + ∑ β kq xq − ∑ β kj x j + cf ( k −1) 2 +1 + 1 − c × ε k , 1 ≤ k ≤ 6
q 1 =j 1
=
.
yk = 
0.5Z + 0.5Z + cf
2
k >6
+ 1 − c × εk ,
1
2

( k −1) 2  +1

(13)

Model 3: There are two factors and genotypes impact on 6 traits. That is, R = 2 and
T
γ = diag ( D1 , D2 ) , where Di = (1,…,1) for i = 1,2 . In details,
np
nr

r r
0.5
0.5
Z
Z
x
β
β kjp x jp + cf ( k −1) 5 +1 + 1 − c 2 × ε k , 1 ≤ k ≤ 6
+
+
−

∑
∑
2
1
kq q


q 1 =j 1
=
.
yk = 
0.5Z + 0.5Z + cf
2
k >6
+ 1 − c × εk ,
1
2
( k −1) 5 +1


(14)

Model 4: There are five factors and genotypes impact on one trait. That is, R = 5 and
T
γ = diag ( D1 , D2 , D3 , D4 , D5 ) , where Di = (1,…,1) for i = 1,…,5 . In details,
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np
nr

2
r r
p p
1
0.5Z1 + 0.5Z 2 + ∑ β kq xq − ∑ β kj x j + cf ( k −1) 2 +1 + 1 − c × ε k , k =
1
1
q
j
=
=
.
yk = 
0.5Z + 0.5Z + cf
2
k >1
+ 1 − c × εk ,
1
2
( k −1) 2  +1


(15)

Model 5: There are only two factors and genotypes impact on one trait. That is, R = 2 and
T
γ = diag ( D1 , D2 ) , where Di = (1,…,1) for i = 1,2 . In details,
np
nr

r r
+
−
+
β
β kpj x jp + cf ( k −1) 5 +1 + 1 − c 2 × ε k , k =
Z
Z
x
0.5
0.5
1

∑
∑
kq q
2
1


j =1
q =1
.
yk = 
0.5Z + 0.5Z + cf
2
+ 1 − c × εk ,
k >1
2
1
( k −1) 5 +1


(16)

Model 6: There is K factors and genotypes impact on 6 traits. That is, R = K , γ = I , and
c = 1 . In details,
np
nr

2
r r
p p
0.5Z1 + 0.5Z 2 + ∑ β kq xq − ∑ β kj x j + cf k + 1 − c × ε k , 1 ≤ k ≤ 6
yk = 
.
q 1 =j 1
=

2
k >6
0.5Z1 + 0.5Z 2 + cf k + 1 − c × ε k ,
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(17)

Results
To evaluate the type I error rates of the proposed test TOWmuT, we set λk = 0 for
k = 1,…, K in the 6 models. We consider different sample sizes, different significance
levels, different models, and different types of traits. In our simulations we consider 10
traits (K = 10). In each simulation scenario, the p-values of TOWmuT are estimated by
1000 permutations and the type I error rates of TOWmuT are evaluated using 10,000
replicated samples. For 10,000 replicated samples, the 95% confidence intervals (CIs) for
the estimated type I error rates of nominal levels 0.05 and 0.01 are (0.046, 0.054) and
(0.008, 0.012), respectively. The estimated type I error rates of TOWmuT are summarized
in Tables 3.1 and 3.2. From these two tables, we can see that 70 out of 72 (greater than
95%) estimated type I error rates are within the 95% CIs and the two estimated type I error
rates not within the 95% CIs (0.05555 and 0.01295) are very close to the bound of the
corresponding 95% CI, which indicates that TOWmuT is valid.
For power comparisons, we consider different values of heritability, different
models, different types of traits, different percentages of protective variants, different
values of between-factor correlation, and different values of within-factor correlation. In
each of the simulation scenarios, the p-values of TOWmuT, AWRR and single-TOW are
estimated using 1,000 permutations and the p-values of MANOVA, GAMuT, and MSKAT
are estimated using asymptotic distributions. The powers of all of the six tests are evaluated
using 1,000 replicated samples at a significance level of 0.05.
Figure 3.1 gives the power comparisons of the six tests (Single-TOW, MSKAT,
AWRR, MANOVA, GAMuT, and TOWmuT) for the power as a function of the total
heritability based on the six models for 10 quantitative traits. This figure shows that (1)
TOWmuT is consistently the most powerful one among the six tests; (2) MANOVA is the
second most powerful when genotypes impact on multiple traits (models 1-3 and 6) while
AWRR is the second most powerful when genotypes impact on a single trait (models 4-5);
(3) MSKAT is consistently less powerful than other multivariate tests probably because
SKAT gives larger weights than that of TOW to only those variants with MAF in the range
(0.01,0.035) and there are only 8% variants with MAF in the range (0.01,0.035) in Sgene
which our simulations are based on; and (4) MSKAT and GAMuT have similar powers in
all six models.
Figure 3.2 gives the power comparisons of the five tests (Single-TOW, AWRR,
MSKAT, GAMuT, and TOWmuT) for the power as a function of the total heritability for
the mixture of 5 quantitative traits and 5 qualitative traits. We only compare the powers of
five tests because MANOVA has inflated type I error rate in this case. This figure shows
that (1) TOWmuT is consistently the most powerful one among the five tests; (2) AWRR
is second most powerful when genotypes impact on multiple traits (models 1-3 and 6) while
MSKAT and GAMuT are second most powerful when genotypes impact on a single trait
(models 4-5); (3) MSKAT and GAMuT have similar powers in all six models; and (4)
single-TOW is consistently less powerful than other four multivariate tests because we
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keep correlations between traits similar to that in Figure 3.1 such that correlations between
original quantitative traits are larger than that in Figure 3.1.
We also compare the powers of the six tests for the power as a function of the
within-factor correlation for models 1-5 and between-factor correlation for model 6 for 10
quantitative traits (Figure B.3.1). As shown in this figure, the power of single-TOW is
robust to the between-factor correlation or the within-factor correlation since the minimum
p-value-based approach is largely unaffected by the trait correlation (Wu and Pankow
2016). However, with the increasing of the between-factor correlation or within-factor
correlation, the power of other five tests essentially increases. Other patterns of the power
comparisons are similar to those of in Figure B.3.1.
Power comparisons of the six tests for the power as a function of the percentage of
protective variants for 10 quantitative traits are given by Figure B.3.2. This figure shows
that the power of all six tests are robust to the percentage of protective variants, therefore,
all of these methods are robust to the directions of the genetic effects. Other patterns of the
power comparisons are similar to those of in Figure 3.1.
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Application to the COPDGene
Chronic obstructive pulmonary disease (COPD) is a common disease in elderly patients
that causes significant morbidity and mortality [Nazir and Erbland, 2009]. The Genetic
Epidemiology of COPD Study (COPDGene) [Regan et al., 2010] was designed to identify
genetic factors associated with COPD. In this COPDGene study, a total of more than
10,000 subjects have been enrolled including 2/3 non-Hispanic Whites (NHW) and 1/3
African-Americans (AA). In this analysis, we only include 5,430 NHW with no missing
phenotypes. Each of the 5,430 NHW has been genotyped at 630,860 SNPs. Based on the
literature studies of COPD [Han et al., 2011; Chu et al., 2014; Liang et al., 2016], we
selected 7 key quantitative COPD-related phenotypes, including FEV1 (% predicted
FEV1), Emphysema (Emph), Emphysema Distribution (EmphDist), Gas Trapping
(GasTrap), Airway Wall Area (Pi10), Exacerbation frequency (ExacerFreq), Six-minute
walk distance (6MWD), and 4 covariates, including BMI, Age, Pack-Years (PackYear)
and Sex.
To evaluate the performance of our proposed method on a real data set, we applied
six methods (TOWmuT, MANOVA, MSKAT, GAMuT, AWRR, and single-TOW) to the
COPDGene of NHW population to test the association between each of 50-SNP blocks and
the 7 key quantitative COPD-related phenotypes. To identify significant 50-SNP blocks
associated with the phenotypes, we used Bonferroni correction to decide the significance
level. The total number of 50-SNP blocks is 12617, therefore, the Bonferroni corrected
significance level is 0.05/12617 ≈ 4×10-6. Table 3.3 summarized the significant blocks
identified by at least one method. There were total six significant blocks in Table 3. All of
the six blocks have been previously reported to be in association with COPD or lung
functions [Pillai et al., 2009; Cho et al., 2010; Figarska et al., 2014; Lutz et al., 2015].
PDSS1 and ABI1 are located between LOC107984176 and LOC105376467, which are
Intergenic regions and contain the SNPs associated with pulmonary function [Imboden et
al., 2012; Lutz et al., 2015]. From Table 3, we can see that TOWmuT identified four blocks;
AWRR identified two blocks; MANOVA, MSKAT and GAMuT identified one block;
single-TOW did not identify any blocks. From these results, we can see that TOWmuT
identified the most of significant 50-SNP blocks among the six methods, which is
consistent with the results of our simulation studies.
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Discussion
We developed TOWmuT to perform joint analysis of multiple traits in gene-based
association studies based on the following reasons: (1) multiple related traits are usually
measured in genetic association studies of complex diseases; (2) there is increasing
evidence showing that pleiotropy is a widespread phenomenon in complex diseases; and
(3) there is a shortage of gene-based approaches for multiple traits. We used extensive
simulation studies to compare the performance of TOWmuT with MANOVA, MSKAT,
AWRR, GAMuT and Single-TOW. Our results showed that TOWmuT has correct type I
error rates and is consistently more powerful than other five methods. Additionally, the
real data analysis results demonstrated that the proposed method has great potential in
gene-based association study for complex diseases with multiple phenotypes such as
COPD.
Recently, it has become a major focus of investigation to identify a small number
of rare causal variants that contribute to complex diseases [Capanu and Ionita-Laza, 2015].
Several methods to pinpoint the causal variants have been developed for testing the
association with a single trait. These methods include backward elimination (BE) method
[Ionita-Laza et al., 2014], hierarchical model method [Ionita-Laza et al., 2014], and
adaptive combination of p-values method [Lin, 2016]. To extend the TOWmuT method to
identify a small number of causal variants which are associated with multiple traits, we can
use the BE method. In each step, we remove one variant that has the smallest contribution
to the association between multiple traits and the set of variants and then we evaluate the
p-value for testing association between multiple traits and the remaining variants by
TOWmuT. Causal variants are the set of variants corresponding to the smallest p-value.
The computation time required for running TOWmuT depends on the sample size,
the number of variants in the genomic region, the number of traits, and the number of
permutations. The running time of TOWmuT with 1000 permutations on a data set with
5000 individuals, 7 traits and 10 variants in a genomic region on a laptop with 4 Intel Cores
@ 3.30GHz and 4 GB memory is about 0.14s. To perform genome-wide association
studies, we can first select genomic regions that show evidence of association based on a
small number of permutations (e.g. 1,000), and then a large number of permutations are
used to test the selected regions.
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Tables and Figures
Table 3.1. The estimated type I error rates of TOWmuT for 10 quantitative traits under
each model with covariates.

Sample Size

α = 0.05

α = 0.01

Model

500

1000

2000

1

0.05365

0.0515

0.0515

2

0.0521

0.0528

0.0504

3

0.0513

0.0540

0.0503

4

0.0514

0.0511

0.05

5

0.05381

0.04825

0.05

6

0.0482

0.0508

0.05325

1

0.01165

0.0098

0.0117

2

0.012

0.01015

0.0102

3

0.01175

0.01075

0.0113

4

0.01145

0.01075

0.0118

5

0.01141

0.01095

0.0117

6

0.0097

0.0105

0.01185
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Table 3.2. The estimated type I error rates of TOWmuT for the mixture of five quantitative
traits and five qualitative traits under each model with covariates.

Sample Size

α = 0.05

α = 0.01

Model 500

1000

2000

1

0.05365

0.05385

0.05005

2

0.0511

0.0483

0.05115

3

0.0508

0.05375

0.052

4

0.0529

0.04915

0.0536

5

0.054

0.05355

0.04825

6

0.05555

0.0493

0.0529

1

0.0105

0.01295

0.00995

2

0.0105

0.009

0.0097

3

0.01145

0.0104

0.0101

4

0.01065

0.00945

0.01165

5

0.0118

0.0105

0.00875

6

0.01195

0.00935

0.01105
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Table 3.3. Significant blocks identified by at least one method (p-values less than 4×10-6)
and the corresponding p-values in the analysis of COPDGene.
CHR

2

4

POS1

POS2

17800098

1784191

5

17

14527883

1456970

7

40

10

26908475

15

78593362

Genes

TOWmuT

MANOVA

MSKAT

GAMuT

AWRR

NFE2L2

0.20883

2.62E-06

0.02508

0.02505

0.25796

HHIP

1.00E-07

7.71E-06

0.03992

0.03984

0

4.00E-06

0.04050

0.01242

0.01247

1.6E-05

1.00E-07

0.00191

0.70349

0.70357

5.6E-06

2.90E-06

0.00037

0.06255

0.06252

0

9.01E-05

4.78E-05

2.25E-06

6.42E-07

0.04849

2715009

PDSS1,

3

ABI1

7882591

IREB2,

7

AGPHD1

SingleTOW
0.1546
8
0.0008
5
0.0284
5
0.2348
4

PSMA4,
15

78826180

7900644

CHRNA5,

2

CHRNA3,

0.3764
3

CHRNB4

15

79006582

7926781

ADAMTS

7

7

49

0.0195
3

Figure 3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR,
MANOVA, GAMuT and TOWmuT) for the power as a function of total heritability for 10
quantitative traits with covariates. The sample size is 1000. The between-factor correlation
is 0.3 and the within-factor correlation is 0.7. The percentage of the causal variants is 0.2.
All causal variants are risk variants.
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Figure 3.2. Power comparisons of the five tests (Single-TOW, AWRR, GAMuT, MSKAT
and TOWmuT) for the power as a function of heritability for the mixture of half
quantitative traits and half qualitative traits with covariates. The sample size is 1000.
Covariance matrix of 10 traits is similar to that of 10 quantitative traits with between-factor
correlation being 0.3 and the within-factor correlation being 0.7. The percentage of the
causal variants is 0.2. All causal variants are risk variants.
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Appendix A: Supplementary Tables
Table A.1.1. The estimated type I error rates of four methods for quantitative traits and
variance model 2. We use 10,000 replicates. This set of simulations is based on Sgene1.

Sample size

𝛼𝛼 = 0.05

𝛼𝛼 = 0.01

500

1000

2000

CCA

0.049

0.05165

0.05505

Single-TOW

0.05055

0.05325

0.05345

WSRR

0.0472

0.0488

0.0505

AWRR

0.0534

0.054

0.0502

CCA

0.0099

0.0116

0.0115

Single-TOW

0.01125

0.0118

0.012

WSRR

0.0086

0.0084

0.0103

AWRR

0.0107

0.0114

0.0104
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Table A.1.2. The estimated type I error rates of four methods for qualitative traits and
variance model 2. We use 10,000 replicates. This set of simulations is based on Sgene1.

Sample size

𝛼𝛼 = 0.05

𝛼𝛼 = 0.01

500

1000

2000

CCA

0.0473

0.05225

0.0539

Single-TOW

0.0521

0.0559

0.0508

WSRR

0.0485

0.0493

0.0522

AWRR

0.0469

0.0493

0.05235

CCA

0.00975

0.0106

0.012

Single-TOW

0.00975

0.01045

0.00955

WSRR

0.0093

0.0109

0.0106

AWRR

0.01115

0.0104

0.012

60

Appendix B: Supplementary Figures
Figure B.1.1. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of heritability for quantitative traits and variance model
2. The sample size is 1000 and ρ = 0.5 . The percentage of the causal variants is 0.1. All
causal variants are risk variants. The total number of traits is 10. This set of simulations is
based on Sgene1.
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Figure B.1.2. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of percentage of protective variants for quantitative traits
and variance model 2. The sample size is 1000, the percentage of causal variants is 0.2, the
total heritability is 0.03, and ρ = 0.5 . The total number of traits is 10. This set of
simulations is based on Sgene1.
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Figure B.1.3. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of the percentage of causal variants for quantitative traits
and variance model 2. The sample size is 1000, ρ = 0.5 , and the total heritability is 0.03.
All causal variants are risk variants. The total number of traits is 10. This set of simulations
is based on Sgene1.
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Figure B.1.4. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of heritability for qualitative traits and variance model
1. The sample size is 1000 and ρ = 0.5 . The percentage of the causal variants is 0.1. All
causal variants are risk variants. The total number of traits is 10. This set of simulations is
based on Sgene1.
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Figure B.1.5. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of percentage of protective variants for qualitative traits
and variance model 1. The sample size is 1000, the percentage of causal variants is 0.2, the
total heritability is 0.03, and ρ = 0.5 . The total number of traits is 10. This set of
simulations is based on Sgene1.
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Figure B.1.6. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of the percentage of causal variants for qualitative traits
and variance model 1. The sample size is 1000, ρ = 0.5 , and the total heritability is 0.03.
All causal variants are risk variants. The total number of traits is 10. This set of simulations
is based on Sgene1.
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Figure B.1.7. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of heritability for qualitative traits and variance model
2. The sample size is 1000 and . The percentage of the causal variants is 0.1. All causal
variants are risk variants. The total number of traits is 10. This set of simulations is based
on Sgene1.
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Figure B.1.8. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of percentage of protective variants for qualitative traits
and variance model 2. The sample size is 1000, the percentage of causal variants is 0.2, the
total heritability is 0.03, and ρ = 0.5 . The total number of traits is 10. This set of
simulations is based on Sgene1.
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Figure B.1.9. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of the percentage of causal variants for qualitative traits
and variance model 2. The sample size is 1000, ρ = 0.5 , and the total heritability is 0.02.
All causal variants are risk variants. The total number of traits is 10. This set of simulations
is based on Sgene1.
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Figure B.1.10. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of heritability for quantitative traits under variance
model 1. The sample size is 1000 and ρ = 0.5 . The percentage of the causal variants is 0.1.
All causal variants are risk variants. This set of simulations is based on Sgene2
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Figure B.1.11. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of percentage of protective variants for quantitative traits
under variance model 1. The sample size is 1000, the percentage of causal variants is 0.2,
the total heritability is 0.03, and ρ = 0.5 . This set of simulations is based on Sgene2.
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Figure B.1.12. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of the percentage of causal variants for quantitative traits
under variance model 1. The sample size is 1000 and ρ = 0.5 , and the total heritability is
0.03. All causal variants are risk variants. The total number of traits is 10. This set of
simulations is based on Sgene2.
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Figure B.1.13. Power comparisons of the four tests (WSRR, AWRR, CCA and SingleTOW) for the power as a function of LP for quantitative traits under variance model 1. LP
represents the number of traits positively correlated with risk variants. The sample size is
1000 and the total heritability is 0.015. All causal variants are risk variants. The total
number of traits is 10. This set of simulations is based on Sgene2.
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Figure B.2.1. Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHTO and MANOVA) for the power as a function of the effect size (model 1). Sample size is
1000. Total number of traits is 20. The significance level is 5 × 10−8 . The number of
replicates is 500. The number of permutations is 108 .
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Figure B.3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR,
MANOVA, GAMuT and TOWmuT) for the power as a function of within-factor
correlation for models 1-5 and between-factor correlation for model 6 for 10 quantitative
traits with covariates. The sample size is 1000. The percentage of the causal variants is
0.2. All causal variants are risk variants and ρ = 0.5 is for models 1-5. Heritabilities for
models 1-6 are 0.05, 0.09, 0.08, 0.03, 0.03, and 0.06, respectively.
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Figure B.3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR,
MANOVA, GAMuT and TOWmuT) for the power as a function of the percentage of
protective variants for 10 quantitative traits with covariates. The sample size is 1000. The
percentage of the causal variants is 0.2. The between-factor correlation is 0.3 and the
within-factor correlation is 0.7.

76

